0002-6216 : Verzenio 200 mg Oral Tablet


NDC0002-6216
Labeler: Eli Lilly and Company
Product Type: Human Prescription Drug
Drug Name:  Verzenio
Dosage Form: Oral Tablet
Application #: NDA208716
Rev. Date: 


Appearance:


Markings: Lilly;200
Shapes:  Oval
Colors:  White
Size (mm): 15
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0002-6216-54: 1 BLISTER PACK IN 1 CARTON (0002‑6216‑54) > 14 TABLET IN 1 BLISTER PACK

Active Ingredients:

  • Abemaciclib

Dosage Strength:

  • 200 mg

Inactive Ingredients:

  • Microcrystalline Cellulose
  • Lactose Monohydrate
  • Croscarmellose Sodium
  • Silicon Dioxide
  • Sodium Stearyl Fumarate
  • Water
  • Polyvinyl Alcohol, Unspecified
  • Polyethylene Glycol, Unspecified
  • Titanium Dioxide
  • Talc
  • Ferric Oxide Yellow
  • Ferric Oxide Red

Pharmaceutical Classes:

  • Kinase Inhibitors [MoA]
  • Kinase Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 0002-4483 Verzenio 50 mg Oral Tablet by Eli Lilly and Company
  • 0002-4815 Verzenio 100 mg Oral Tablet by Eli Lilly and Company
  • 0002-5337 Verzenio 150 mg Oral Tablet by Eli Lilly and Company

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0002-6216 QR Code

< Prev: 0002-6145Next: 0002-7140 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 August 2018.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA